{"DataElement":{"publicId":"3624735","version":"1","preferredName":"Cytogenetic Analysis Remission Occurrence Type","preferredDefinition":"A description of the cytogenetic remission.","longName":"3624384v1.0:2939257v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3624384","version":"1","preferredName":"Cytogenetic Analysis Remission Occurrence","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._An abatement in intensity or degree (as in the manifestations of a disease)._An instance of something happening, such as an event or incident.","longName":"3624382v1.0:2234856v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3624382","version":"1","preferredName":"Cytogenetic Analysis Remission","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:An abatement in intensity or degree (as in the manifestations of a disease).","longName":"C18280:C18246","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Remission","conceptCode":"C18246","definition":"An abatement in intensity or degree (as in the manifestations of a disease).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD5DBBC5-BBC6-CF4D-E040-BB89AD43556B","latestVersionIndicator":"Yes","beginDate":"2012-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-10-31","modifiedBy":"ONEDATA","dateModified":"2012-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD5DBBC5-BBD4-CF4D-E040-BB89AD43556B","latestVersionIndicator":"Yes","beginDate":"2012-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-10-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2939257","version":"1","preferredName":"Cytogenetic Analysis Remission Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._An abatement in intensity or degree (as in the manifestations of a disease)._Type; a subdivision of a particular kind of thing.","longName":"CYTG_RMN_TYPE","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Minor","valueDescription":"Minor 36 to 95 percent Ph positive metaphases","ValueMeaning":{"publicId":"3135440","version":"1","preferredName":"Minor 36 to 95 percent Ph positive metaphases","longName":"3135440","preferredDefinition":"36 to 95 percent Ph positive metaphases","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD37F83-96EF-AFE4-E040-BB89AD4316C9","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FD37F83-9708-AFE4-E040-BB89AD4316C9","beginDate":"2009-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","deletedIndicator":"No"},{"value":"Major","valueDescription":"Major less than 35 percent Ph positive metaphases","ValueMeaning":{"publicId":"3135439","version":"1","preferredName":"Major less than 35 percent Ph positive metaphases","longName":"3135439","preferredDefinition":"Less than 35 percent Ph positive metaphases","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD37F83-96CC-AFE4-E040-BB89AD4316C9","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FD37F83-96E5-AFE4-E040-BB89AD4316C9","beginDate":"2009-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3135438","version":"1","preferredName":"Cytogenetic Analysis Remission Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:An abatement in intensity or degree (as in the manifestations of a disease).:Type; a subdivision of a particular kind of thing.","longName":"C18280:C18246:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Remission","conceptCode":"C18246","definition":"An abatement in intensity or degree (as in the manifestations of a disease).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD37F83-9689-AFE4-E040-BB89AD4316C9","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7328DDDC-574F-4875-E040-BB89AD43777C","latestVersionIndicator":"Yes","beginDate":"2009-09-09","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-09","modifiedBy":"KUMMEROA","dateModified":"2012-03-26","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964929","version":"1","longName":"2012r1: CML Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedDiagnosis:diseaseStatusCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"cml_base_tx_rsp_cyto_spe","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the type of cytogenet","type":"Preferred Question Text","description":"Specify the type of cytogenetic remission:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD85E748-2137-C89B-E040-BB89AD430798","latestVersionIndicator":"Yes","beginDate":"2012-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-02","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":". System generated def displayed as alt def. AK 6/4/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}